Sangamo Therapeutics
Yahoo Finance • last year
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q3 2023 Earnings Call Transcript
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q3 2023 Earnings Call Transcript November 2, 2023 Operator: Good morning, and thank you for standing by. Welcome to the Sangamo Third Quarter 2023 Teleconference Call. At this time, all participant... Full story
Yahoo Finance • 2 years ago
Two Big Pharma Companies Bow Out Of Neurology Drug Partnerships With Sangamo
https://cdn.benzinga.com/files/images/story/2023/03/20/sgmo_logo_light__df15263084666d45f8f072d9581b42da.png?optimize=medium&dpr=2&auto=webp&crop=1200%2C800 Two big-name partners have walked away from partnerships with Sangamo Therapeutic... Full story
Yahoo Finance • 3 years ago
Sangamo Therapeutics Announces First Quarter 2022 Conference Call and Webcast
BRISBANE, Calif., April 28, 2022--(BUSINESS WIRE)--Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that the company has scheduled the release of its first quarter 2022 financial results after the mark... Full story
